Bioequivalence Study Comparing Two Formulations of Escitalopram

NCT01395433 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

H. Lundbeck A/S